Cargando…

Artificial Intelligence and Pharmacometrics: Time to Embrace, Capitalize, and Advance?

Detalles Bibliográficos
Autores principales: Chaturvedula, Ayyappa, Calad‐Thomson, Stacie, Liu, Chao, Sale, Mark, Gattu, Nandu, Goyal, Navin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657004/
https://www.ncbi.nlm.nih.gov/pubmed/31006175
http://dx.doi.org/10.1002/psp4.12418
_version_ 1783438723514368000
author Chaturvedula, Ayyappa
Calad‐Thomson, Stacie
Liu, Chao
Sale, Mark
Gattu, Nandu
Goyal, Navin
author_facet Chaturvedula, Ayyappa
Calad‐Thomson, Stacie
Liu, Chao
Sale, Mark
Gattu, Nandu
Goyal, Navin
author_sort Chaturvedula, Ayyappa
collection PubMed
description
format Online
Article
Text
id pubmed-6657004
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-66570042019-07-31 Artificial Intelligence and Pharmacometrics: Time to Embrace, Capitalize, and Advance? Chaturvedula, Ayyappa Calad‐Thomson, Stacie Liu, Chao Sale, Mark Gattu, Nandu Goyal, Navin CPT Pharmacometrics Syst Pharmacol Perspectives John Wiley and Sons Inc. 2019-06-05 2019-07 /pmc/articles/PMC6657004/ /pubmed/31006175 http://dx.doi.org/10.1002/psp4.12418 Text en © 2019 The Authors CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology and Therapeutics. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Perspectives
Chaturvedula, Ayyappa
Calad‐Thomson, Stacie
Liu, Chao
Sale, Mark
Gattu, Nandu
Goyal, Navin
Artificial Intelligence and Pharmacometrics: Time to Embrace, Capitalize, and Advance?
title Artificial Intelligence and Pharmacometrics: Time to Embrace, Capitalize, and Advance?
title_full Artificial Intelligence and Pharmacometrics: Time to Embrace, Capitalize, and Advance?
title_fullStr Artificial Intelligence and Pharmacometrics: Time to Embrace, Capitalize, and Advance?
title_full_unstemmed Artificial Intelligence and Pharmacometrics: Time to Embrace, Capitalize, and Advance?
title_short Artificial Intelligence and Pharmacometrics: Time to Embrace, Capitalize, and Advance?
title_sort artificial intelligence and pharmacometrics: time to embrace, capitalize, and advance?
topic Perspectives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657004/
https://www.ncbi.nlm.nih.gov/pubmed/31006175
http://dx.doi.org/10.1002/psp4.12418
work_keys_str_mv AT chaturvedulaayyappa artificialintelligenceandpharmacometricstimetoembracecapitalizeandadvance
AT caladthomsonstacie artificialintelligenceandpharmacometricstimetoembracecapitalizeandadvance
AT liuchao artificialintelligenceandpharmacometricstimetoembracecapitalizeandadvance
AT salemark artificialintelligenceandpharmacometricstimetoembracecapitalizeandadvance
AT gattunandu artificialintelligenceandpharmacometricstimetoembracecapitalizeandadvance
AT goyalnavin artificialintelligenceandpharmacometricstimetoembracecapitalizeandadvance